Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
Go back to Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update| (NASDAQ: TSHA) | Delayed: 6.92 +0.39 (5.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.53 | 52 Week High | $ | |||
| Open | $6.47 | 52 Week Low | $ | |||
| Day High | $7.06 | P/E | N/A | |||
| Day Low | $6.46 | EPS | $ | |||
| Volume | 1,298,659 | |||||
| (NASDAQ: TSHA) | Delayed: 6.92 +0.39 (5.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.53 | 52 Week High | $ | |||
| Open | $6.47 | 52 Week Low | $ | |||
| Day High | $7.06 | P/E | N/A | |||
| Day Low | $6.46 | EPS | $ | |||
| Volume | 1,298,659 | |||||

